F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$97.70M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.67M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,955
Open	36.19
Previous Close	36.66
Day's Range	36.19 - 36.77
52-Week Low	22.53
52-Week High	40.10
Beta	n/a
Holdings	42
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

53.87% of assets

Name	Symbol	Weight
Cogent Biosciences, Inc.	COGT	7.55%
Travere Therapeutics, Inc.	TVTX	7.35%
LivaNova PLC	LIVN	7.08%
Spyre Therapeutics, Inc.	SYRE	6.77%
Mirum Pharmaceuticals, Inc.	MIRM	5.54%
United Therapeutics Corporation	UTHR	4.41%
Guardant Health, Inc.	GH	4.31%
Nektar Therapeutics	NKTR	3.69%
Veradermics, Incorporated	MANE	3.68%
BridgeBio Pharma, Inc.	BBIO	3.49%

Performance

LFSC had a total return of 57.79% in the past year, including dividends. Since the fund's inception, the average annual return has been 27.52%.